Description
The IVD Market in South Korea, 2024 offers a comprehensive overview of the in vitro diagnostics (IVD) market in South Korea and the factors shaping it. The report presents South Korea’s IVD revenues for 2023 and forecasts for 2028, segmented into clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.
The report is designed to provide the reader with an overview of the IVD market in South Korea and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators, and controls of the following sub-segments:
- Clinical Chemistry: routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC). Includes urinalysis and blood chemistry testing. Hematology and hemoglobin tests are also included in this segment.
- Immunoassays: hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology and common infectious diseases (HIV, hepatitis, influenza).
- Microbiology and Molecular Testing: manual and automated tests, culture media (to be prepared or ready to use), latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma, nucleic acid testing.
- Point-of-Care Testing: all POC tests for cardiology, toxicology, coagulation, diabetes, infectious diseases. Includes POC and non-POC blood gas and electrolytes. Also includes glucose self-monitoring tests.
- Histology/Cytology: PAP, HE, IHC, ISH, FISH, primary and secondary antibodies.
Scope
The information in the report was gathered using both primary and secondary research methods including interviews with industry participants and representatives, completed during the period of January 2024 and February 2024. These interviews were with government officials, medical device regulators, domestic-based distributors, health care providers and global market participants. Secondary data included the use of government databases, company literature, medical journals and reports.
All market data pertains to the South Korean IVD market at the manufacturers’ level. Market data is presented for the 2023 year with forecast data provided for 2028. Compound annual growth rates (CAGRs) are provided for the 2023-2028 period.
Table of Contents
Chapter 1: Executive Summary
Industry Overview
Scope and Methodology
South Korea IVD Market Summary
- Figure 1-1: South Korea In Vitro Diagnostic Sales by Market Segment, 2023-2028 ($M)
Company Profiles
Chapter 2: South Korea Overview
Population
- Table 2-1: Total Midyear Population by Broad Age Group: South Korea, 2010-2050 (million persons)
- Figure 2-1: Total Midyear Population by Broad Age Group: South Korea, 2010-2050 (million persons)
- Figure 2-2: Total Number of Births in South Korea, by Year, 1990-2010 and Forecast 2020-2050
- Figure 2-3: South Korea Life Expectancy at Birth in Years, 2010-2050
Health Indicators
General Health
Disease Profiles in South Korea
- Table 2-2: Number of Deaths Attributed to Non-Communicable Diseases, by Type of Disease, All Sexes, 2019
- Table 2-3: Top 5 Cancers Affecting South Korean Population (ranked by total number of cases), 2020
- Figure 2-4: Tuberculosis – New and Relapse Case Notifications, 2000-2021
Economy and Health Spending
- Figure 2-5: South Korea GDP, GDP (PPP) and Health Spending, 1990-2020 ($B)
- Figure 2-6: South Korea Distribution of Income or Consumption by Quintile, 2011-2016
Health Infrastructure
- Figure 2-7: Healthcare System in Korea
Medical Facilities
Hospital Bed Density
- Figure 2-8: Hospital Bed Density per 1,000 Population, by Country, 2023 Estimates
Physicians
- Figure 2-9: Physician Density per 1,000 Population, by Country, 2023 Estimates
Medical Tourism
- Figure 2-10: South Korea Medical Tourism Visits Reported, 2009-2021 (# of patients)
Medical Device Regulation
- Figure 2-11: Medical Device Approval Process, South Korea
Regulatory News
Precision Medicine and NGS
Physician Shortage in South Korea
- Table 2-4: Market Divers and Inhibitors for Entering South Korea’s Medical Device Market
- Figure 2-12: South Korea Medical Device Market Growth as a Global Comparison, 2023-2028 CAGR (%)
Chapter 3: IVD Markets in South Korea
Market Summary
- Table 3-1: South Korea In Vitro Diagnostic Sales, by Extracted Market Segment (Blood Bank Screening Immunoassays, Blood Gas Analysis, Blood Screening NAT, CTC, General Chemistry, Hematology, Hemoglobin, HPV, ID/AST, Infectious Disease Immunoassays, Microbiology Molecular, Non-infectious Disease Immunos, Other Histology, POC Glucose, POC Infectious Disease, POC Other, Urinalysis, Others), 2023-2028 ($M)
- Figure 3-1: South Korea In Vitro Diagnostic Sales, by Broad Market Segment (Clinical Chemistry, Histology, Immunoassay, Microbiology, POC, Other), 2023-2028 ($M)
- Figure 3-2: South Korea In Vitro Diagnostic Sales, by Broad Market Segment (Clinical Chemistry, Histology, Immunoassay, Microbiology, POC, Other), 2023 Market Distribution (%)
Clinical Chemistry
Hematology
Hemoglobin
Blood Gas Analysis
Urinalysis
- Figure 3-3: South Korea – Clinical Chemistry Market (Blood Gas Analysis, General Chemistries, Hematology, Hemoglobin, Urinalysis), 2023-2028
Immunoassay
Non Infectious Disease Immunoassays
Infectious Disease Immunoassays
- Figure 3-4: South Korea Immunoassay Infectious Disease Market Distribution, by Disease (Blook Bank Screening Immunos, HAIs/Sepsis, Hepatitis, HIV, Mycology, Parasitology, Respiratory [w/ COVID], STD, ToRCH, Other [EBV, Chagas, Dengue, Malaria, etc.]), 2023 (%)
Blood Bank Screening Immunoassays
- Figure 3-5: South Korea – Immunoassay Market Value, by Segment (Blood Bank Screening, Infectious Disease, Non-infectious Disease), 2023-2028 ($M)
Microbiology/Molecular
ID/AST
- Figure 3-6: South Korea ID/AST Manual, Auto Market Distribution, 2023 (%)
Molecular Diagnostics
- Figure 3-7: South Korea Molecular Infectious Disease Market Distribution, by Segment (Molecular Blood Screening – NAT, Molecular HAI [c. diff/sepsis, MRSA, VRE, others], Molecular Hepatitis, Molecular HIV, Molecular Mycobacteria/TB, Molecular Other Microbiology, Molecular STD, Respiratory w/ COVID), 2023 (%)
Blood Screening
- Figure 3-8: South Korea Microbiology/Molecular Testing Market Value, by Segment (Blood Screening-NAT, ID/AST, Molecular Dx), 2023-2028 ($M)
Point-of-Care
POC Glucose
POC Infectious Disease
- Figure 3-9: South Korea POC Market Value, by Segment (Glucose, Infectious Disease, Other POC), 2023-2028 ($M)
Histology
HPV
CTC
- Figure 3-10: South Korea – Histology Market (HPV, CTC, Others), 2023-2028 ($M)
Chapter 4: Major Market Participants
Abbott Laboratories
- Table 4-1: Abbott Corporate Summary
Company Overview
Becton Dickinson (BD)
- Table 4-2: BD Corporate Summary
Company Overview
Bertis, Inc
- Table 4-3: Bertis Corporate Summary
Company Overview
bioMerieux SA
- Table 4-4: bioMerieux SA Corporate Summary
Company Overview
Bio-Rad Laboratories Inc.
- Table 4-5: Bio-Rad Labs Corporate Summary
Company Overview
Danaher Corporation
- Table 4-6: Danaher Corporation Summary
Company Overview
Fujirebio Inc
- Table 4-7: Fujirebio Corporate Summary
Company Overview
Gencurix
- Table 4-8: Gencurix Corporation Summary
Company Overview
Roche Diagnostic Corporation
- Table 4-9: Roche Diagnostic Corporate Summary
Company Overview
SD Biosensor
- Table 4-10: SD Biosensor Corporate Summary
Company Overview
Seegene, Inc.
- Table 4-11: Seegene Corporate Summary
Company Overview
Siemens Healthineers GmbH
- Table 4-12: Siemens Healthineers Corporate Summary
Company Overview
Sugentech
- Table 4-13: Sugentech Corporate Summary
Company Overview
Sysmex Corporation
- Table 4-14: Sysmex Corporate Summary
Company Overview
Thermo Fisher Scientific
- Table 4-15: Thermo Fisher Corporate Summary
Company Overview
